Table 4.
Haplotype | Frequency/% | Odds ratio [95% CI] | ||
---|---|---|---|---|
DRB1.DQA1.DQB1 | Cases | Controls | ||
0701.0301.0202 | 3.1 | 0.8 | 1.93 [0.68–5.48] | 5.28 [1.77–15.81] |
0701.0302.0202 | 2.0 | 0.4 | ||
04.0302.0302 | 4.2 | 0.8 | 1.37 [0.47–4.06] | 3.75 [1.25–11.31] |
0301.0501.0201 | 18.9 | 5.1 | 1.00 (reference) | 2.73 [1.52–4.91] |
08.0401.0402 | 2.2 | 0.8 | ||
04.0301.0302 | 9.3 | 3.3 | 0.72 [0.37–1.37] | 1.96 [0.97–3.92] |
0901.0302.0202 | 2.7 | 0.3 | ||
0901.0301.0202 | 2.9 | 1.8 | 0.53 [0.24–1.18] | 1.44 [0.60–3.47] |
0701.0201.0202 | 7.3 | 6.4 | 0.37 [0.20–0.66] | 1.00 (reference) |
13.0102.05 | 2.4 | 2.7 | 0.32 [0.13–0.78] | 0.87 [0.35–2.17] |
01.0101.05 | 5.6 | 6.2 | 0.29 [0.16–0.52] | 0.78 [0.40–1.54] |
13.0102.06 | 4.2 | 4.7 | 0.26 [0.14–0.50] | 0.72 [0.35–1.47] |
13.0505.0301 | 1.5 | 1.7 | 0.28 [0.09–0.87] | 0.77 [0.23–2.53] |
04.0301.0301 | 0.9 | 1.3 | ||
1001.0101.05 | 2.2 | 3.1 | 0.20 [0.09–0.47] | 0.56 [0.23–1.33] |
11.0505.0319 | 2.4 | 3.9 | 0.22 [0.10–0.45] | 0.59 [0.26–1.32] |
08.0401.0319 | 2.9 | 4.0 | 0.21 [0.09–0.47] | 0.57 [0.24–1.34] |
13.0103.06 | 2.7 | 3.9 | 0.18 [0.07–0.41] | 0.48 [0.19–1.18] |
13.0201.0202 | 0.9 | 1.8 | ||
13.0505.0319 | 0.3 | 1.0 | ||
14.0101.05 | 0.7 | 1.7 | ||
11.0102.05 | 1.1 | 1.4 | 0.14 [0.04–0.43) | 0.38 [0.12–1.18] |
11.0102.0602 | 2.0 | 4.5 | 0.13 [0.05–0.30) | 0.35 [0.14–0.86] |
16.0102.05 | 0.7 | 1.5 | ||
1501.0102.0602 | 1.1 | 1.8 | 0.13 [0.03–0.45] | 0.34 [0.09–1.27] |
1503.0102.0602 | 4.0 | 11.1 | 0.11 [0.05–0.22] | 0.30 [0.14–0.62] |
0302.0401.0402 | 1.8 | 6.4 | 0.09 [0.04–0.22] | 0.25 [0.10–0.64] |
11.0505.0301 | 0.9 | 3.6 | 0.08 [0.03–0.23] | 0.22 [0.07–0.64] |
12.0101.05 | 0.9 | 3.4 | 0.07 [0.02–0.19] | 0.19 [0.06–0.55] |
Rares | 0.26 [0.16–0.41] | 0.70 [0.41–1.20] |
The study is underpowered to detect rare effects, therefore only haplotypes with a combined frequency > 1% are listed and only those with a frequency > 1.5% are used to calculate odds ratios and 95% confidence intervals.